Status:
RECRUITING
Microbiota and Metabolomics of Intestinal Type of Gastric Cancer
Lead Sponsor:
Jilin University
Conditions:
Gastric Cancer
Eligibility:
All Genders
18-80 years
Brief Summary
Compare with the gastric cavity without cancerous transformation in atrophic gastritis, analyze the microbiota and metabolomics changes in intestinal type of gastric cancer under the background of atr...
Detailed Description
This study adopts a prospective cohort study. The expected recruitment time for all participants is 6 months, and all cases are cases who would receive magnifying endoscopy examination. The extent of ...
Eligibility Criteria
Inclusion
- •Intestinal type of gastric cancer or atrophic gastritis
- Underwent Endoscopic submucosal dissection（ESD）
Exclusion
- • have simultaneously other cancer
- have severe systemic inflammatory disease ,serious illness such as diabetes, chronic lung diseases
Key Trial Info
Start Date :
March 31 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
August 30 2025
Estimated Enrollment :
32 Patients enrolled
Trial Details
Trial ID
NCT06079554
Start Date
March 31 2024
End Date
August 30 2025
Last Update
April 12 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
the First Hospital of Jilin University
Changchun, Jilin, China, 130021